Orbicular Pharmaceutical Technologies

Orbicular Pharmaceutical Technologies company information, Employees & Contact Information

Orbicular Pharmaceutical Technologies Pvt. Ltd. is a Specialty Pharmaceutical Company that develops niche and complex pharmaceutical dosage forms for licensing to global partners. We are based out of Hyderabad, India and have a state-of-the-art Research facility of 100,000 sq. ft +, accommodating end-to-end capabilities for product delivery across entire product R&D lifecycle. We are a leading Research company backed by a strong team of 300+ competent scientists focussed on making us a one-stop shop to ensure seamless delivery of highly complex products. Our focus is on developing generic pharmaceutical product and 505(b)(2) products with complex chemistry, technological barriers, and limited competition for the global markets. We have extensive experience in developing cutting edge solutions, proprietary processes and technologies to deliver products across multiple delivery platforms, including nano-suspensions, nano-emulsions, liposomes, nanoparticles, and long-acting polymeric injectable suspensions. Our pipeline includes Complex Injectables, Topicals, Ophthalmics, Parenterals, Nasal Sprays /Inhalations and Complex Peptide combination products that target various treatment indications. Our pipeline is characteristic of product domain that is complex, has entry barriers and a is lucrative. We are an outcome driven and value generating organization creating growth partnerships for global pharma players across the entire spectrum of Complex Generics. Our vision is aptly captured in our tag line: Performance Excellence Delivered ! To know more about Orbicular Pharmaceutical Technologies, visit https://orbicular.co.in or reach out to us at hr.dept@orbicular.co.in!

Company Details

Employees
221
Founded
-
Address
53 Pragathi Nagar Road, Kakatiya Hills,aleap Industrial Area,gajularamaram,hyderabad,india
Industry
Research Services
NAICS
Scientific Research and Development Services
Research and Development in the Physical, Engineering, and Life Sciences
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
HQ
Bachupally, Telangana
Looking for a particular Orbicular Pharmaceutical Technologies employee's phone or email?

Orbicular Pharmaceutical Technologies Questions

News

Radius Pharmaceuticals Announces Victory in Patent Infringement Case Against Orbicular Pharmaceutical Technologies for Osteoporosis Treatment TYMLOS(R) - The Marion Star

Radius Pharmaceuticals Announces Victory in Patent Infringement Case Against Orbicular Pharmaceutical Technologies for Osteoporosis Treatment TYMLOS(R) The Marion Star

Radius Pharmaceuticals Announces Victory in Patent Infringement Case Against Orbicular Pharmaceutical Technologies for Osteoporosis Treatment TYMLOS(R) - USA Today

Radius Pharmaceuticals Announces Victory in Patent Infringement Case Against Orbicular Pharmaceutical Technologies for Osteoporosis Treatment TYMLOS(R) USA Today

Radius Pharmaceuticals Announces Victory in Patent Infringement Case Against Orbicular Pharmaceutical Technologies for Osteoporosis Treatment TYMLOS(R) - ACCESS Newswire

Radius Pharmaceuticals Announces Victory in Patent Infringement Case Against Orbicular Pharmaceutical Technologies for Osteoporosis Treatment TYMLOS(R) ACCESS Newswire

Tata Capital Healthcare Fund Pumps USD 20 Mn into Orbicular Pharmaceutical to Fuel R&D - Entrepreneur

Tata Capital Healthcare Fund Pumps USD 20 Mn into Orbicular Pharmaceutical to Fuel R&D Entrepreneur

Strides and Orbicular enter into a strategic partnership to develop a range of nasal sprays - Indian Pharma Post

Strides and Orbicular enter into a strategic partnership to develop a range of nasal sprays Indian Pharma Post

Novo Sues Orbicular to Block Copies of Saxenda Weight-Loss Drug - Bloomberg Law News

Novo Sues Orbicular to Block Copies of Saxenda Weight-Loss Drug Bloomberg Law News

Tata Capital arm invests $20 mn in Orbicular Pharmaceutical Technologies - Moneycontrol

Tata Capital arm invests $20 mn in Orbicular Pharmaceutical Technologies Moneycontrol

Tata Capital arm injects USD 20 million in Orbicular Pharmaceutical Technologies - Medical Dialogues

Tata Capital arm injects USD 20 million in Orbicular Pharmaceutical Technologies Medical Dialogues

Tata Capital Healthcare Fund Invests $20M in Orbicular Pharmaceutical to boost R&D - YourStory.com

Tata Capital Healthcare Fund Invests $20M in Orbicular Pharmaceutical to boost R&D YourStory.com

Tata Capital Healthcare Fund II invests $20M in Orbicular Pharmaceutical Technologies - Indian Startup News

Tata Capital Healthcare Fund II invests $20M in Orbicular Pharmaceutical Technologies Indian Startup News

Tata Capital Healthcare Fund II Invests $20 Million In Orbicular Pharmaceutical Technologies - BW Healthcare World

Tata Capital Healthcare Fund II Invests $20 Million In Orbicular Pharmaceutical Technologies BW Healthcare World

Tata Capital Healthcare Fund II invests upto $20 M in Orbicular Pharma Technologies - BioSpectrum India

Tata Capital Healthcare Fund II invests upto $20 M in Orbicular Pharma Technologies BioSpectrum India

Tata Capital Healthcare Fund II Invests $20 Mn in Orbicular Pharmaceutical Technologies - Digital Health News

Tata Capital Healthcare Fund II Invests $20 Mn in Orbicular Pharmaceutical Technologies Digital Health News

Strides, Orbicular sign pact to jointly develop a range of nasal sprays - Express Pharma

Strides, Orbicular sign pact to jointly develop a range of nasal sprays Express Pharma

Strides Pharma Shares Rise, Partners with Orbicular for Nasal Spray - Equitypandit

Strides Pharma Shares Rise, Partners with Orbicular for Nasal Spray Equitypandit

Alembic Pharma buys out Orbicular's stake in Aleor Dermaceuticals - Business Standard

Alembic Pharma buys out Orbicular's stake in Aleor Dermaceuticals Business Standard

The Broken Bridge Between Geology and Museums - eos.org

The Broken Bridge Between Geology and Museums eos.org

Strides, Orbicular ink pact to develop range of nasal sprays - Medical Dialogues

Strides, Orbicular ink pact to develop range of nasal sprays Medical Dialogues

Alembic Pharmaceuticals announces US FDA final approval for formoterol fumarate inhalation solution - Express Pharma

Alembic Pharmaceuticals announces US FDA final approval for formoterol fumarate inhalation solution Express Pharma

Alembic Pharma forms JV with Orbicular for derma products - Business Standard

Alembic Pharma forms JV with Orbicular for derma products Business Standard

Top Orbicular Pharmaceutical Technologies Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant